Literature DB >> 17879080

The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico.

A Arredondo, A Barceló.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17879080     DOI： 10.1007/s00125-007-0828-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.

Authors:  Armando Arredondo; Alexis Zúñiga
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  The cost of diabetes in Latin America and the Caribbean.

Authors:  Alberto Barceló; Cristian Aedo; Swapnil Rajpathak; Sylvia Robles
Journal:  Bull World Health Organ       Date:  2003-03-11       Impact factor: 9.408

3.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

4.  [Prevalence and interrelations of noncommunicable chronic diseases and cardiovascular risk factors in Mexico. Final outcomes from the National Health Survey 2000].

Authors:  Oscar Velázquez-Monroy; Martín Rosas Peralta; Agustín Lara Esqueda; Gustavo Pastelín Hernández; Claudia Sànchez-Castillo; Fause Attie; Roberto Tapia Conyer; Claudia Castillo
Journal:  Arch Cardiol Mex       Date:  2003 Jan-Mar
  4 in total
  8 in total

1.  Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico.

Authors:  A Arredondo; E de Icaza
Journal:  Diabetologia       Date:  2009-06-06       Impact factor: 10.122

2.  The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach.

Authors:  Grégoire de Lagasnerie; Anne-Sophie Aguadé; Pierre Denis; Anne Fagot-Campagna; Christelle Gastaldi-Menager
Journal:  Eur J Health Econ       Date:  2017-02-11

3.  Measuring the impact of diabetes on life expectancy and disability-free life expectancy among older adults in Mexico.

Authors:  Flávia C D Andrade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-12-22       Impact factor: 4.077

Review 4.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review.

Authors:  Till Seuring; Olga Archangelidi; Marc Suhrcke
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

5.  Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.

Authors:  Luz Maria Sánchez-Romero; Joanne Penko; Pamela G Coxson; Alicia Fernández; Antoinette Mason; Andrew E Moran; Leticia Ávila-Burgos; Michelle Odden; Simón Barquera; Kirsten Bibbins-Domingo
Journal:  PLoS Med       Date:  2016-11-01       Impact factor: 11.069

6.  Mexico's household health expenditure on diabetes and hypertension: What is the additional financial burden?

Authors:  Juan Pablo Gutierrez; Sebastian Garcia-Saiso; Belkis M Aracena
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

7.  Patient perceptions of their glycemic control and its influence on type 2 diabetes outcomes: an international survey of online communities.

Authors:  Kristina Simacek; Christopher Curran; Peter Fenici; Ricardo Garcia-Sanchez
Journal:  Patient Prefer Adherence       Date:  2019-02-18       Impact factor: 2.711

8.  Health disparities from economic burden of diabetes in middle-income countries: evidence from México.

Authors:  Armando Arredondo; Gabriela Reyes
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.